Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request, 18022-18023 [2022-06593]
Download as PDF
18022
Federal Register / Vol. 87, No. 60 / Tuesday, March 29, 2022 / Notices
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Monday, May 2, 2022. The agenda,
roster, and minutes will be available
from Ms. Heather Phelps, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland
20857. Ms. Phelps’ phone number is
(301) 427–1128.
SUPPLEMENTARY INFORMATION:
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. app., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
lotter on DSK11XQN23PROD with NOTICES1
II. Agenda
On Thursday, May 12, 2022, the
Council meeting will convene at 10:00
a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting
will begin with an introduction of NAC
members, an update on AHRQ
activities, and a discussion about new
opportunities with AHRQ’s new
Director. The agenda will also include
discussions about AHRQ and the
Patient-Centered Outcomes Research
(PCOR) Trust Fund and AHRQ’s role in
conducting and supporting health
services research, analysis and
evaluations focused on understanding
the effects of healthcare financing
policies. The meeting will adjourn at
3:00 p.m. The meeting is open to the
public. For information regarding how
to access the meeting as well as other
meeting details, including information
on how to make a public comment,
please go to https://www.ahrq.gov/news/
events/nac/. The final agenda will be
VerDate Sep<11>2014
17:01 Mar 28, 2022
Jkt 256001
available on the AHRQ website no later
than Thursday, May 5, 2022.
Dated: March 23, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–06527 Filed 3–28–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will be closed to the public.
DATES: See below for dates of meetings:
1. Healthcare Research Training (HCRT)
Dates: May 19–20, 23, 2022
July 15, 2022
2. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: June 8–9, 2022
3. Healthcare Information Technology
Research (HITR)
Date: June 9–10, 2022
4. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: June 15–16, 2022
5. Health System and Value Research
(HSVR)
Date: June 16–17, 2022
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Jenny Griffith, Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427–
1557.
SUPPLEMENTARY INFORMATION: In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5
U.S.C. app. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
SUMMARY:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Services Research Initial Review Group
Committee. The subcommittee meetings
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. app. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Dated: March 23, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–06525 Filed 3–28–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10398 #74 and
#76]
Medicaid and Children’s Health
Insurance Program (CHIP) Generic
Information Collection Activities:
Proposed Collection; Comment
Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
On May 28, 2010, the Office
of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA)
guidance related to the ‘‘generic’’
clearance process. Generally, this is an
expedited process by which agencies
may obtain OMB’s approval of
collection of information requests that
are ‘‘usually voluntary, low-burden, and
uncontroversial collections,’’ do not
raise any substantive or policy issues,
and do not require policy or
methodological review. The process
requires the submission of an
overarching plan that defines the scope
of the individual collections that would
fall under its umbrella. On October 23,
2011, OMB approved our initial request
to use the generic clearance process
under control number 0938–1148
(CMS–10398). It was last approved on
April 26, 2021, via the standard PRA
process which included the publication
of 60- and 30-day Federal Register
notices. The scope of the April 2021
umbrella accounts for Medicaid and
SUMMARY:
E:\FR\FM\29MRN1.SGM
29MRN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 60 / Tuesday, March 29, 2022 / Notices
CHIP State plan amendments, waivers,
demonstrations, and reporting. This
Federal Register notice seeks public
comment on one or more of our
collection of information requests that
we believe are generic and fall within
the scope of the umbrella. Interested
persons are invited to submit comments
regarding our burden estimates or any
other aspect of this collection of
information, including: The necessity
and utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments must be received by
April 12, 2022.
ADDRESSES: When commenting, please
reference the applicable form number
(see below) and the OMB control
number (0938–1148). To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: CMS–10398 (#ll)/OMB
control number: 0938–1148, Room C4–
26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may access CMS’
website at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Following
is a summary of the use and burden
associated with the subject information
collection(s). More detailed information
can be found in the collection’s
supporting statement and associated
materials (see ADDRESSES).
Generic Information Collections
1. Title of Information Collection:
Coverage of Routine Patient Cost for
VerDate Sep<11>2014
17:01 Mar 28, 2022
Jkt 256001
Items & Services in Qualifying Clinical
Trials; Type of Information Collection
Request: Revised; Use: Section 210 of
the Consolidated Appropriations Act of
2021 amended section 1905(a) of the
Social Security Act (the Act) to add a
new mandatory benefit at 1905(a)(30).
The new benefit mandates coverage of
routine patient services and costs
furnished in connection with
participation by Medicaid beneficiaries
in qualifying clinical trials. Routine
costs for services provided in
connection with participation in a
qualifying clinical trial generally
include any item or service provided to
the individual under the qualifying
clinical trial, including any item or
service provided to prevent, diagnose,
monitor, or treat complications resulting
from participation in the qualified
clinical trial, to the extent that the
provision of such items or services to
the individual would otherwise be
covered under the state plan or waiver.
We propose that States and territories
review the preprints completed for a
Medicaid beneficiary to receive
coverage of routine patient services and
costs furnished in connection with
participation in qualifying clinical
trials. Completion of the preprint pages
verifies in the Medicaid state plan that
the mandatory clinical trials benefit is
being furnished by a state. Completion
of the preprint verifies that the
requirements of a federally sponsored
clinical trial is appropriate for the
Medicaid beneficiary. Form Number:
CMS–10398 (#74) (OMB control
number: 0938–1148); Frequency: Once
and on occasion; Affected Public: State,
Local, or Tribal Governments; Number
of Respondents: 56; Total Annual
Responses: 66; Total Annual Hours: 61.
(For policy questions regarding this
collection contact Myla Adams at 410–
786–8107.)
2. Title of Information Collection:
Expressions of interest in the Improving
Maternal Health by Reducing Low-Risk
Cesarean Delivery Affinity Group; Type
of Information Collection Request: New
collection of information request; Use:
State Medicaid and CHIP agencies are
given the opportunity to submit the
attached Expression of Interest Form
regarding participation in the Improving
Maternal Health by Reducing Low-Risk
Cesarean Delivery Affinity Group.
Information requested will be used to
see if each state meets the criteria for
participation in the Affinity Group.
Criteria for affinity group participation
include:
• Well-articulated goals for improving
low-risk cesarean delivery rates,
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
18023
• An understanding of the state’s
challenges and opportunities related to
low-risk cesarean deliveries,
• Access to low-risk cesarean delivery
data, including the ability to report the
Core Set measure Low-Risk Cesarean
Delivery (LRCD–CH),
• Identification of a well-rounded
state team willing to work about 10 to
15 hours each month (depending on
role, project, and team size) on the state
quality improvement (QI) project, and
• Commitment to action, with
support from Medicaid and/or CHIP
leadership.
Once participating in the Affinity
Group, a states will meet monthly
virtually for workshops and one-on-one
state coaching calls, learning from QI
advisors, subject matter experts, and
peers in order to test, implement, and
assess their data-driven QI change idea.
Form Number: CMS–10398 (#76)
(OMB control number: 0938–1148);
Frequency: Once; Affected Public: State,
Local, or Tribal Governments; Number
of Respondents: 20; Total Annual
Responses: 20; Total Annual Hours:
140. (For policy questions regarding this
collection contact Kristen Zycherman at
410–786–6974.)
Dated: March 24, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–06593 Filed 3–28–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10433 and
CMS–276]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
SUMMARY:
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 87, Number 60 (Tuesday, March 29, 2022)]
[Notices]
[Pages 18022-18023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06593]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10398 #74 and #76]
Medicaid and Children's Health Insurance Program (CHIP) Generic
Information Collection Activities: Proposed Collection; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: On May 28, 2010, the Office of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA) guidance related to the
``generic'' clearance process. Generally, this is an expedited process
by which agencies may obtain OMB's approval of collection of
information requests that are ``usually voluntary, low-burden, and
uncontroversial collections,'' do not raise any substantive or policy
issues, and do not require policy or methodological review. The process
requires the submission of an overarching plan that defines the scope
of the individual collections that would fall under its umbrella. On
October 23, 2011, OMB approved our initial request to use the generic
clearance process under control number 0938-1148 (CMS-10398). It was
last approved on April 26, 2021, via the standard PRA process which
included the publication of 60- and 30-day Federal Register notices.
The scope of the April 2021 umbrella accounts for Medicaid and
[[Page 18023]]
CHIP State plan amendments, waivers, demonstrations, and reporting.
This Federal Register notice seeks public comment on one or more of our
collection of information requests that we believe are generic and fall
within the scope of the umbrella. Interested persons are invited to
submit comments regarding our burden estimates or any other aspect of
this collection of information, including: The necessity and utility of
the proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by April 12, 2022.
ADDRESSES: When commenting, please reference the applicable form number
(see below) and the OMB control number (0938-1148). To be assured
consideration, comments and recommendations must be submitted in any
one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: CMS-10398 (#__)/OMB
control number: 0938-1148, Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may
access CMS' website at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Following is a summary of the use and burden
associated with the subject information collection(s). More detailed
information can be found in the collection's supporting statement and
associated materials (see ADDRESSES).
Generic Information Collections
1. Title of Information Collection: Coverage of Routine Patient
Cost for Items & Services in Qualifying Clinical Trials; Type of
Information Collection Request: Revised; Use: Section 210 of the
Consolidated Appropriations Act of 2021 amended section 1905(a) of the
Social Security Act (the Act) to add a new mandatory benefit at
1905(a)(30). The new benefit mandates coverage of routine patient
services and costs furnished in connection with participation by
Medicaid beneficiaries in qualifying clinical trials. Routine costs for
services provided in connection with participation in a qualifying
clinical trial generally include any item or service provided to the
individual under the qualifying clinical trial, including any item or
service provided to prevent, diagnose, monitor, or treat complications
resulting from participation in the qualified clinical trial, to the
extent that the provision of such items or services to the individual
would otherwise be covered under the state plan or waiver.
We propose that States and territories review the preprints
completed for a Medicaid beneficiary to receive coverage of routine
patient services and costs furnished in connection with participation
in qualifying clinical trials. Completion of the preprint pages
verifies in the Medicaid state plan that the mandatory clinical trials
benefit is being furnished by a state. Completion of the preprint
verifies that the requirements of a federally sponsored clinical trial
is appropriate for the Medicaid beneficiary. Form Number: CMS-10398
(#74) (OMB control number: 0938-1148); Frequency: Once and on occasion;
Affected Public: State, Local, or Tribal Governments; Number of
Respondents: 56; Total Annual Responses: 66; Total Annual Hours: 61.
(For policy questions regarding this collection contact Myla Adams at
410-786-8107.)
2. Title of Information Collection: Expressions of interest in the
Improving Maternal Health by Reducing Low-Risk Cesarean Delivery
Affinity Group; Type of Information Collection Request: New collection
of information request; Use: State Medicaid and CHIP agencies are given
the opportunity to submit the attached Expression of Interest Form
regarding participation in the Improving Maternal Health by Reducing
Low-Risk Cesarean Delivery Affinity Group. Information requested will
be used to see if each state meets the criteria for participation in
the Affinity Group. Criteria for affinity group participation include:
Well-articulated goals for improving low-risk cesarean
delivery rates,
An understanding of the state's challenges and
opportunities related to low-risk cesarean deliveries,
Access to low-risk cesarean delivery data, including the
ability to report the Core Set measure Low-Risk Cesarean Delivery
(LRCD-CH),
Identification of a well-rounded state team willing to
work about 10 to 15 hours each month (depending on role, project, and
team size) on the state quality improvement (QI) project, and
Commitment to action, with support from Medicaid and/or
CHIP leadership.
Once participating in the Affinity Group, a states will meet
monthly virtually for workshops and one-on-one state coaching calls,
learning from QI advisors, subject matter experts, and peers in order
to test, implement, and assess their data-driven QI change idea.
Form Number: CMS-10398 (#76) (OMB control number: 0938-1148);
Frequency: Once; Affected Public: State, Local, or Tribal Governments;
Number of Respondents: 20; Total Annual Responses: 20; Total Annual
Hours: 140. (For policy questions regarding this collection contact
Kristen Zycherman at 410-786-6974.)
Dated: March 24, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2022-06593 Filed 3-28-22; 8:45 am]
BILLING CODE 4120-01-P